A Propensity Score-Matched Study on the Changes of TB Status and TB-IGRA Values in Patients with Psoriasis with Latent TB Receiving Secukinumab

INTRODUCTION: The utilization of biologics in patients with psoriasis with latent tuberculosis infection (LTBI) has garnered significant attention. Although the tuberculosis (TB) safety profile of second-generation biologics, including secukinumab, has been partially confirmed in both clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yue, Mi, Wenyao, Wang, Jinqiu, Wen, Dingke, Wang, Yiyi, Gu, Yuanxia, Hao, Dan, Yan, Wei, Chen, Xuerong, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539261/
https://www.ncbi.nlm.nih.gov/pubmed/37615837
http://dx.doi.org/10.1007/s13555-023-00998-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539261/
https://www.ncbi.nlm.nih.gov/pubmed/37615837
http://dx.doi.org/10.1007/s13555-023-00998-w

Ejemplares similares